visit sniclinic dot com here

Permitted vs. Not Permitted Pet Food Claims in Canada 

Permitted vs. Not Permitted Pet Food Claims in Canada 


Pet food claims in Canada follow a structured regulatory framework that ensures all statements on packaging, websites, and marketing materials are truthful, evidence based, and not misleading. Oversight is shared by the Competition BureauCanadian Food Inspection Agency (CFIA), and Health Canada, each of which plays a different role in evaluating how claims are presented and interpreted. While Canada does not require pre-market approval or prescribe specific nutrient standards for most pet foods, companies remain fully responsible for the accuracy and substantiation of every claim they make, both on and off the label. 

This guide outlines the types of pet food claims that are permitted and not permitted in Canada and explains the regulatory basis, documentation expectations, and enforcement considerations behind them. If your team needs support with pet food claim development or compliance, the SNI Regulatory team is available to assist and help streamline your market entry and product compliance.  

Show Table of Contents
Hide Table of Contents

Before assessing which pet food claims are permitted or not permitted in Canada, it is important to understand the regulatory framework that applies to these products. Pet food labelling and advertising fall under the Competition Act and the Consumer Packaging and Labelling Act, which require that all pet food representations are truthful, not misleading, and supported by adequate evidence.  

CFIA oversees import admissibility, safety verification, and marketplace monitoring for animal foods, while Health Canada is responsible for determining when a statement implies a therapeutic purpose and therefore falls under veterinary drug oversight or other regulatory frameworks.  

Oversight Under the Competition Act and Consumer Packaging and Labelling Act 

The Competition Bureau plays a central role in ensuring that pet food marketing practices meet Canadian advertising standards. Its oversight extends to how claims are presented, interpreted, and qualified across all consumer-facing materials, including packaging, online listings, promotional content, and point-of-sale displays.  

The Bureau assesses whether the pet food’s overall impression conveyed to purchasers aligns with the available evidence, with particular attention to claims related to performance, composition, and ingredient attributes. Companies are expected to maintain adequate and objective claim substantiation, and to ensure that marketing practices do not exaggerate or imply benefits beyond what the supporting data can demonstrate. 

CFIA’s Role in Safety, Import Oversight, and Label Accuracy 

CFIA’s role in pet food oversight focuses on ensuring that products entering or circulating within Canada meet safety, admissibility, and traceability expectations. The agency reviews ingredient suitability, evaluates product classifications during import and inspection activities, and verifies that documentation accurately reflects the composition and intended use of the product.  

CFIA may intervene when discrepancies raise concerns about safety, labelling accuracy, or product handling, particularly in cases where ingredient sourcing or processing conditions pose potential risks. Its compliance actions range from requesting corrective labelling to conducting broader marketplace follow up when systemic issues are identified. 

Health Canada’s Role in Therapeutic Boundary Setting 

Health Canada’s role is to define the boundary between general nutritional or function claims and statements that imply a therapeutic benefit. When a claim suggests that a pet food can influence a disease, correct a physiological dysfunction, or produce a clinical outcome, it is no longer considered a conventional food claim. In such cases, the product falls under a different regulatory framework, such as the veterinary drug pathway, which requires formal pre-market review, evidence of safety and efficacy, and compliance with drug manufacturing and labelling standards. This distinction ensures that pet products marketed as foods do not convey drug-like benefits unless they meet the regulatory requirements applied to therapeutic products. 

Health-related statements on pet food labels and advertising are carefully evaluated in Canada because they shape how consumers understand a product’s purpose and suitability. Regulators distinguish between general function claims, which are permitted when supported by appropriate evidence, and therapeutic representations, which are not allowed for conventional pet foods. Clearly understanding this boundary is essential for developing compliant marketing language and ensuring that claims remain within the regulatory scope of pet food rather than entering veterinary drug territory. 

Permitted Health Function Claims for Pet Foods 

General function or wellness claims are acceptable when they describe supportive roles related to normal physiology and are substantiated with appropriate evidence. Claims may be used when they are: 

  • factually accurate 
  • supported by data relevant to the actual formulation 
  • presented without therapeutic implication 
  • consistent across packaging, websites, and promotional materials 
  • based on recognized scientific methods 

For instance, a “supports skin and coat health” claim may be used when ingredient functionality and product testing demonstrate a measurable effect on normal skin or coat condition. 

Additionally, a “complete and balanced” claim, or other claims of that nature, is permitted when supported by credible documentation that is aligned with established industry practices. 

Prohibited Therapeutic and Disease Claims on Pet Foods  

Statements that suggest a product prevents, treats, or cures a disease cannot be used on standard pet food labelling and marketing. These types of claims imply a therapeutic outcome and, in most cases, require formal evaluation under drug legislation prior to the product’s entry into the Canadian market.  

Pet foods that cross this line can face enforcement action and may be reclassified as veterinary drugs. Once reclassified, the product is subject to an entirely different set of regulatory requirements. If a pet product is imported or sold in Canada as a food but makes claims that fall into the therapeutic category, it is considered non-compliant. In these cases, regulators may apply corrective measures such as detaining shipments, requesting relabelling, issuing a stop sale, or taking additional actions depending on the seriousness of the non-compliance and the associated risks. 

Examples of therapeutic claims not permitted on pet food products:  

  • prevents kidney disease 
  • treats arthritis pain 
  • controls blood glucose 
  • cures skin infections 

Origin and comparative claims are widely used on pet food labels and advertising, and both influence how consumers interpret product quality, sourcing, and performance. Origin claims describe where the ingredients come from or where the product was manufactured, while comparative claims evaluate one product against another on attributes such as nutrient levels, palatability, or overall performance. Because these claims can strongly affect purchasing decisions, Canadian regulators assess them closely to ensure they are truthful, not misleading, and supported by clear, verifiable evidence.

Requirements for Origin Statements in Canada

Origin statements must accurately reflect ingredient sourcing and processing activities and must meet Competition Bureau thresholds such as those that apply to “Product of Canada” and “Made in Canada.” For complex formulations, the declared origin must reflect the overall sourcing profile rather than the final packaging location. Origin references cannot imply safety, quality, or nutritional superiority unless supported by evidence, and they must remain consistent across packaging, websites, and retail materials to avoid creating a misleading general impression. Learn more about regulations for products claiming Canadian origin: “Product of Canada” vs. “Made in Canada” Differences and Conditions of Use

Substantiation Expectations for Comparative Claims

Comparative claims require objective, defensible evidence that directly relates to the attribute being compared. Claims may assess nutrient content, palatability performance, formulation improvements, or other measurable characteristics, provided the comparison uses appropriate methods and evaluates similar product types. The supporting data must be current, statistically reliable, and transparent about the basis of comparison. Claims cannot exaggerate differences, omit qualifying information, or imply broad superiority when the evidence supports only a specific aspect of product performance.

Managing Consumer Interpretation and Regulatory Expectations

Regulators evaluate origin and comparative claims based on how a typical purchaser would interpret them, not solely on their technical accuracy. This means the framing, context, and clarity of the claim all influence compliance. Manufacturers must ensure that supporting evidence aligns directly with the claim presented, that data remains up to date, and that claim language across all channels presents a consistent and accurate representation of the documented facts.

As with function and comparative claims, nutrient claims must adhere to Canadian regulatory requirements and may only be used when substantiated and presented in language that aligns with accepted regulatory terminology. 

Permitted Nutrient Content Claims 

Nutrient content claims such as “high in protein,” “source of omega 3,” or “reduced fat” are acceptable when supported by verifiable analytical data. In accordance with Health Canada’s expectations for substantiation, nutrient levels must be confirmed using recognized, validated laboratory methods. Documentation must demonstrate accuracy and traceability, and any nutrient referenced in a claim must appear in the guaranteed analysis or be supported by technical records available for regulatory review. 

Analytical Expectations for Nutrient Substantiation 

To substantiate nutrient claims, manufacturers are expected to use testing approaches that are recognized and scientifically reliable. Most nutrient testing relies on established methods published by the Association of Official Analytical Chemists (AOAC), which are widely used across food and feed sectors to produce consistent and defensible data. 

From a Health Canada and Competition Bureau perspective, testing must confirm that nutrient levels presented to consumers are accurate and representative of the product as sold. Manufacturers should test batches that reflect normal production and maintain documentation outlining how results were generated. As nutrient levels can vary between lots, testing should be based on representative samples rather than a single data point. This ensures that any nutrient referenced on packaging or in marketing materials is supported by reliable evidence that can be provided to regulators upon request. 

Non-Compliant Nutrient Claims and Common Errors 

Nutrient claims are considered non-compliant when the representations made are inaccurate, insufficiently supported, or create a misleading impression regarding the product’s nutritional properties.  

Common issues include claims that: 

  • overstate digestibility, bioavailability, or physiological impact beyond what the evidence can substantiate 
  • suggest suitability for all life stages or species without data that aligns with recognized standards for nutritional adequacy 
  • rely on outdated or unverified analysis following formulation adjustments, supplier changes, or process modifications 
  • use comparative nutrient statements without current, defensible data supporting the asserted differences 

These deficiencies can mislead purchasers and compromise the accuracy and reliability of the nutrient claims presented on the label or in advertising. When such issues are identified by Competition Bureau, CFIA, or Health Canada during inspections, marketplace monitoring, or complaint-based reviews, regulators may employ corrective measures. Depending on the seriousness and scope of the non-compliance, this may include a request to revise the claim language, relabel the product, remove affected lots from sale, or implement additional oversight to ensure that future nutrient claims are properly substantiated and presented in accordance with regulatory expectations. 

Ingredient-related claims must use truthful, recognizable common names that accurately reflect the product’s composition. While pet foods are not subject to the feed ingredient listing requirements used for livestock feeds, the naming of ingredients must still comply with Competition Bureau standards for truthful representation. Ingredient names cannot mislead purchasers, exaggerate the significance of an ingredient, or imply properties or functions that the ingredient does not provide. 

Permitted Ingredient-Based Claims 

Ingredient claims are permitted when they describe the presence of an ingredient factually and proportionally. Acceptable examples include: 

  • real chicken 
  • made with salmon 
  • formulated with sweet potatoes 

These statements may be used when they reflect actual inclusion levels consistent with the impression created by the claim. To comply with expectations from CFIA and the Competition Bureau, such statements must not misrepresent the proportion, quality, or functional significance of the named ingredient. 

Prohibited Ingredient Claims and Implied Therapeutic Functions 

Ingredient claims become non-compliant when they imply therapeutic or disease-related effects, as these fall under Health Canada oversight. 

Examples of non-permissible ingredient-linked therapeutic claims include: 

  • turmeric cures joint pain 
  • blueberry blend prevents infections 
  • botanical formula treats inflammation 

Ingredient references must remain within general function boundaries and be supported by evidence demonstrating the role they play in normal nutrition or physiology. Any representation that crosses into therapeutic territory may trigger reclassification as a veterinary drug and result in compliance actions if included on pet food products.  

Requirements for Single-Ingredient Products 

Products marketed as single-ingredient must contain only the named ingredient and no undeclared additives, carriers, processing aids, or functional agents. If CFIA identifies inconsistencies during import verification or marketplace monitoring, regulators may employ corrective actions.  

A product such as dehydrated beef liver treats can be labelled as a single-ingredient item when the only component in the product is beef liver, with no added preservatives, carriers, flavourings, binders, or processing aids. In this case, the ingredient list would state “beef liver” as the sole ingredient, and the product would meet the expectation of being a true single-ingredient item. 

Negative claims and absence statements highlight what is not included in a pet food product, such as “no artificial preservatives” or “grain free.” In Canada, these claims must be truthful, not misleading, and supported by documentation showing that the named ingredient or component is genuinely absent across all production lots. They cannot imply that competing products using permitted ingredients are unsafe or inferior without evidence, and they must avoid suggesting therapeutic benefits unless the product meets the criteria for a veterinary drug. 

Permitted Absence Claims and Substantiation Requirements 

Claims such as “no artificial preservatives” or “no added wheat or soy” are acceptable when supported by production records, supplier documentation, and formulation data that consistently verify the absence of the specified substance. 

Risks and Misleading Nature of Negative Claims 

Negative claims must not create a false sense of uniqueness by highlighting the absence of ingredients that are not typically used in that type of pet food. For example, stating “gluten free” on a product category that does not normally contain gluten can mislead purchasers into believing the product offers a special advantage.  

Additionally, under Competition Bureau guidance, absence statements cannot imply that legal ingredients used by competitors are unsafe or inferior unless that implication is supported by robust evidence. Any statement that overstates the significance of an omission or exaggerates a benefit without substantiation is considered misleading. 

Palatability claims describe how readily pets accept or prefer a product, using phrases such as “dogs love the taste” or “preferred over leading brands.” In Canada, these statements must be supported by structured taste tests or panel evaluations that use appropriate sample sizes and standardized methods. Results must be reproducible, reflective of typical use, and documented in a manner that allows verification by Competition Bureau or CFIA if requested. Additionally, palatability claims cannot be used to imply nutritional adequacy, health benefits, or safety, unless those outcomes are substantiated by additional evidence. 

Evidence Standards for Taste and Preference Claims 

Acceptable palatability claims, such as “pets prefer it” or “picky dogs love it,” must be supported by well-designed taste assessments. These assessments may include one-bowl, two-bowl, or controlled preference tests, provided the methodology is documented, the sample size is appropriate for the species, and the results are statistically meaningful. Manufacturers must retain records that explain how the tests were conducted, how outcomes were measured, and how conclusions were drawn from the data. 

Non-Permitted and Vague Palatability Claims 

Palatability claims become non-compliant when they are vague, exaggerated, or unsupported by measurable test results. Statements such as “pets love it,” “great taste,” or “preferred by all dogs” are not permitted if they imply universal preference, overstate the findings, or lack substantive evidence. For example, a claim like “every dog prefers this flavour” is misleading because it cannot be supported through reasonable testing and suggests a level of certainty that exceeds typical palatability outcomes. Under the expectations of Competition Bureau, taste or preference claims must be specific, evidence based, and communicated in a way that accurately reflects the strength and reliability of the supporting data. 

Pet food off-label advertising in Canada is subject to the same truth-in-advertising requirements that apply to packaging. Claims made in digital spaces, social media, or retail environments must present a consistent and accurate representation of the product and must not introduce new claims that would be prohibited on the label. Competition Bureau and CFIA assess marketing materials in their full context and expect that the overall impression conveyed to purchasers aligns with the available evidence. Any claim that cannot appear on packaging due to substantiation or classification concerns cannot be used in off-label advertising.  

Digital Marketing Compliance Expectations 

Digital content, including website copy, e-commerce listings, comparison tables, and structured data, must accurately reflect the claims permitted on the product label. Statements that appear only online but not on packaging may be considered misleading if they expand the scope of the claim or imply additional attributes not supported by the evidence. Search engine metadata, product descriptions, and promotional banners must also align with labelling rules to avoid creating an inconsistent or exaggerated impression of the product. 

Social Media and Influencer Requirements 

Claims made through captions, hashtags, videos, or influencer partnerships must follow the same substantiation and accuracy requirements as formal advertising. Content posted by brand partners must be reviewed to ensure it does not introduce prohibited therapeutic implications or misrepresent ingredient significance. Paid influencers must use approved language, and disclosures of compensation must follow Canadian advertising standards. 

In-Store and Point-of-Sale Standards 

Retail displays, shelf talkers, brochures, and demonstration scripts must remain consistent with the claims permitted on the label. These materials cannot suggest nutritional, functional, or comparative benefits that have not been substantiated. Retail staff should be trained to differentiate between nutritional claims, general function statements, and therapeutic representations to avoid inadvertently making regulated claims during consumer interactions. If CFIA identifies discrepancies during in-store reviews or marketplace monitoring, corrective actions may include requests to revise marketing materials, remove inaccurate signage, or retrain staff to ensure compliance. 

Canada’s truth-in-advertising requirements also apply to claims relating to natural, organic, and human grade designations. These terms carry specific expectations around composition, sourcing, and processing. The Competition Bureau and CFIA assess them based on whether the overall impression conveyed to purchasers is accurate and fully supported. Claims that overstate quality, imply unproven superiority, or misrepresent how a product was sourced or processed may be considered misleading. 

Natural Claim Criteria 

A natural claim is acceptable only when the finished product contains no artificial ingredients, synthetic substances, or chemically altered components. If only certain ingredients meet natural criteria, this must be clearly disclosed to avoid creating a misleading impression. A natural claim also cannot imply that the product is safer or nutritionally superior unless those outcomes are supported by appropriate evidence and do not cross into therapeutic representations. 

Organic Claim Requirements 

Organic claims are strictly regulated in Canada and may only be used when the product is certified under the Canadian Organic Standards. Products must meet the certification thresholds before using the term organic or displaying the Canada Organic logo. Certified ingredients must be sourced from approved suppliers, and documentation verifying compliance must be available for inspection by CFIA. Any reference to organic content must accurately reflect the formulation and cannot imply full organic certification when only some components qualify. 

Human Grade Claim Requirements 

Human grade claims require that every ingredient and every stage of handling, processing, and storage meet human food standards. This includes sanitation controls, facility requirements, and documentation consistent with human food production. Any step performed under feed-grade conditions invalidates the claim. Under the expectations of Competition Bureau, the term human grade must not be used unless the manufacturer can substantiate full compliance with the standards applied to foods intended for human consumption. 

Pet food claims in Canada must be supported by clear evidence and presented in a way that aligns with federal requirements under Competition Bureau, CFIA, and Health Canada. Whether the claim relates to health, nutrient content, ingredients, palatability, or absence of certain components, the standard remains the same: statements must be truthful, not misleading, and defensible through reliable documentation. Companies that invest in accurate substantiation, maintain consistent messaging across packaging, digital channels, and retail environments, and proactively review claims against regulatory expectations are better positioned to avoid compliance challenges and build consumer trust. 

Evidence-Based Claim Development and Canadian Market Readiness

The SNI Regulatory Affairs team provides specialised support for pet food manufacturers, importers, and brand owners navigating Canada’s complex claim and advertising requirements. With deep expertise in CFIA oversight, Health Canada’s therapeutic boundary, and Competition Bureau advertising standards, SNI helps companies ensure their health, nutrient, ingredient, palatability, and absence claims are accurate, defensible, and fully aligned with Canadian regulatory expectations.

Our team assists at every stage of product and marketplace readiness, from preliminary claim reviews and substantiation assessments to corrective guidance and claim optimization across packaging, digital channels, and retail environments. Whether you are entering the Canadian market or refining an existing portfolio, SNI provides the technical clarity and regulatory insight needed to reduce compliance risk and strengthen consumer trust.

Contact us today to learn how our regulatory experts can support your organization in developing compliant pet food claims, building robust evidence files, and ensuring consistent, regulator-ready messaging across all consumer touchpoints.

💡 More about our services here.
📩 info@sourcenutra.com

Send us a request for support or an introductory call

    Are functional treats or supplement-style pet products regulated differently than regular pet food?

      No. In Canada, ingestible pet treats, toppers, chews, and “functional” products are regulated as pet food unless they make therapeutic representations. Products formulated with botanicals, active ingredients, or supplement-like components must still meet the same truth-in-advertising requirements. If a claim suggests a therapeutic benefit, Health Canada may classify the product as a veterinary drug, triggering pre-market review, safety and efficacy evidence, and drug-labelling requirements.

      Can raw, freeze-dried, or air-dried pet foods make claims about being safer, more digestible, or more biologically appropriate?

        No. Raw and minimally processed pet diets cannot claim enhanced safety, reduced pathogens, or superior nutritional benefits unless these outcomes are supported by validated evidence and do not imply therapeutic effects. CFIA closely monitors raw and dehydrated pet foods during import verification, particularly when animal-origin ingredients may introduce microbiological risks. Claims such as “pathogen free,” “safer than kibble,” or “biologically appropriate for disease prevention” are not permitted unless substantiated and aligned with general food representations rather than therapeutic or safety guarantees.

        These claims require heightened caution. Statements such as “hypoallergenic,” “allergen free,” “low bacteria,” or “free from heavy metals” must be substantiated with rigorous evidence and must not imply disease treatment or prevention. Claims that exaggerate the health significance of allergen absence are considered misleading under Competition Bureau guidance. Additionally, Canada does not permit pathogen-related guarantees unless supported by validated microbiological testing and presented in a manner that avoids implying therapeutic or clinical benefit.

          Yes, but only when supported by objective, verifiable substantiation. Endorsement claims must reflect actual participation by veterinary professionals and cannot imply that the product has therapeutic properties or is effective in managing disease. For example, “formulated by veterinarians” requires documentation showing that qualified veterinarians participated in formulation development. Any claim that suggests medical superiority without evidence, or that crosses into therapeutic territory, would not be compliant.

          Do AAFCO rules apply to pet foods sold in Canada?

          Canada does not require compliance with Association of American Feed Control Officials (AAFCO) naming rules or nutrient standards. However, AAFCO nutrient profiles and feeding trials are recognized as acceptable evidence when supporting claims such as “complete and balanced.” Companies importing products formulated to U.S. More about AAFCO and how it applies to pet food products in our blog: AAFCO Pet Food Standards Explained: U.S., Canada, and Europe  


          Related Posts

          Loading...